MapLight Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 08/14/2026 | 3.69 M | $132.13 M | 0.00% | 8.11% |
| FCPM III SERVICES B.V. | 08/14/2026 | 3.23 M | $115.63 M | 0.00% | 7.10% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 2.78 M | $99.70 M | -0.72% | 6.12% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.95 M | $69.83 M | -2.33% | 4.29% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.42 M | $51.00 M | 1,162.50% | 3.13% |
| BLACKROCK, INC. | 08/07/2026 | 1.03 M | $36.74 M | -23.48% | 2.26% |
| NAN FUNG GROUP HOLDINGS LTD | 08/13/2026 | 971.25 K | $34.81 M | 0.00% | 2.14% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2026 | 950.01 K | $34.05 M | 0.00% | 2.09% |
| SANOFI | 07/28/2026 | 912.04 K | $32.69 M | 0.00% | 2.01% |
| STATE STREET CORP | 08/07/2026 | 852.15 K | $30.54 M | 151.29% | 1.88% |
| FMR LLC | 08/13/2026 | 823.56 K | $29.52 M | 302.71% | 1.81% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 784.15 K | $28.10 M | 8.94% | 1.73% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/11/2026 | 729.93 K | $26.16 M | -27.44% | 1.61% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 685.85 K | $24.58 M | 100.00% | 1.51% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 611.45 K | $21.91 M | 0.00% | 1.35% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2026 | 492.89 K | $17.67 M | 0.00% | 1.08% |
| SIREN, L.L.C. | 08/13/2026 | 450.00 K | $16.13 M | 0.00% | 0.99% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 415.73 K | $14.90 M | 100.00% | 0.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 402.05 K | $14.41 M | -16.45% | 0.89% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 364.71 K | $13.07 M | 0.00% | 0.80% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 171.01 K | $6.13 M | 0.00% | 0.38% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 08/13/2026 | 170.86 K | $6.12 M | -36.19% | 0.38% |
| FREESTONE GROVE PARTNERS LP | 08/14/2026 | 168.91 K | $6.05 M | -46.20% | 0.37% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 136.82 K | $4.90 M | -15.10% | 0.30% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 136.82 K | $4.90 M | 100.00% | 0.30% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 128.84 K | $4.62 M | 100.00% | 0.28% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 08/14/2026 | 125.43 K | $4.50 M | -34.72% | 0.28% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 123.14 K | $4.41 M | -6.17% | 0.27% |
| UBS GROUP AG | 08/13/2026 | 122.03 K | $4.37 M | -48.41% | 0.27% |
| NORTHERN TRUST CORP | 08/13/2026 | 116.65 K | $4.18 M | -20.20% | 0.26% |
| STEMPOINT CAPITAL LP | 08/14/2026 | 106.91 K | $3.83 M | 6.91% | 0.24% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 100.00 K | $3.58 M | 0.00% | 0.22% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 96.76 K | $3.47 M | -14.07% | 0.21% |
| LAZARD ASSET MANAGEMENT LLC | 08/14/2026 | 80.08 K | $2.87 M | -43.61% | 0.18% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 75.00 K | $2.69 M | 0.00% | 0.17% |
| BOXER CAPITAL MANAGEMENT, LLC | 08/14/2026 | 75.00 K | $2.69 M | 100.00% | 0.17% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 70.48 K | $2.53 M | 88.96% | 0.16% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 63.79 K | $2.29 M | 100.00% | 0.14% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 54.53 K | $1.95 M | 14.15% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 54.46 K | $1.95 M | 188.64% | 0.12% |
| HRT FINANCIAL LP | 08/14/2026 | 51.98 K | $1.86 M | 100.00% | 0.11% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 51.92 K | $1.86 M | 12.36% | 0.11% |
| JAIN GLOBAL LLC | 08/14/2026 | 45.55 K | $1.63 M | 100.00% | 0.10% |
| MORGAN STANLEY | 08/13/2026 | 38.30 K | $1.37 M | 25.57% | 0.08% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 35.00 K | $1.25 M | 100.00% | 0.08% |
| WEISS ASSET MANAGEMENT LP | 08/14/2026 | 33.09 K | $1.19 M | 100.00% | 0.07% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 30.41 K | $1.09 M | -22.94% | 0.07% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 26.50 K | $949.65 K | -92.93% | 0.06% |
| CITADEL ADVISORS LLC | 09/02/2026 | 25.75 K | $922.92 K | 100.00% | 0.06% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 25.22 K | $903.96 K | 100.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MapLight Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 121 institutional investors and hedge funds held shares of MapLight Therapeutics Inc.. The most heavily invested institutionals were:
Novo Holdings A/S: 3.69 M
FCPM III SERVICES B.V.: 3.23 M
T. Rowe Price Investment Management, Inc.: 2.78 M
GOLDMAN SACHS GROUP INC: 1.95 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.42 M
BlackRock, Inc.: 1.03 M
58.09% of MapLight Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 27.32 M shares in the last 24 months. This purchase volume represents approximately $540.61 M in transactions.